[Refractory tuberculosis: concept and clinical cases].
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000494:pharmacology; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011031:Pneumothorax, Artificial; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013444:Sulfisoxazole / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D011718:Pyrazinamide; D007612:Kanamycin; D013444:Sulfisoxazole; D004977:Ethambutol; D003523:Cycloserine; D013307:Streptomycin